Stock Events

Stock Events

Biocryst Pharmaceuticals (BO1.F) Q2 2024 Earnings

6MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.29

-0.24

-0.2

-0.16

Details

Expected EPS

-0.1943805465

Actual EPS

-0.157845

Surprise EPS

0.04

Surprise Percent

+18.8%

Description

Biocryst Pharmaceuticals (BO1.F) has reported earnings of -0.157845 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.